Skip to main content

Find Clinical Trials

Home
Conditions
Stage III Ovarian Epithelial Cancer

Clinical trial condition

Stage III Ovarian Epithelial Cancer

Explore clinical trials studying Stage III Ovarian Epithelial Cancer. Study availability and eligibility vary by location and protocol.

25 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Stage III Ovarian Epithelial Cancer trial results

Completed

Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu

NCT00004074

Conditions: Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +257 more
Locations: Ohio State University Medical Center Columbus, Ohio, United States

View Trial Details

Completed

3-AP and Cisplatin in Treating Patients With Recurrent or Persistent Platinum-Resistant Ovarian Epithelial or Primary Peritoneal Cancer

NCT00081276

Conditions: Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +20 more
Locations: Gynecologic Oncology Group Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Imatinib Mesylate in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cancer

NCT00036751

Conditions: Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +20 more
Locations: Southwest Oncology Group (SWOG) Research Base San Antonio, Texas, United States

View Trial Details

Completed

Paclitaxel, Cisplatin, and Topotecan With or Without Filgrastim in Treating Patients With Newly Diagnosed Stage III or Stage IV Epithelial Ovarian Cancer

NCT00002913

Conditions: Adnexal Diseases, Brenner Tumor, Carcinoma, +29 more
Locations: Gynecologic Oncology Group of Arizona Phoenix, Arizona, United States

View Trial Details

Completed

EF5 in Finding Oxygen in Tumor Cells of Patients Who Are Undergoing Surgery or Biopsy for Cervical, Endometrial, or Ovarian Epithelial Cancer

NCT00107445

Conditions: Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +37 more
Locations: Abramson Cancer Center of The University of Pennsylvania Philadelphia, Pennsylvania, United States

View Trial Details